1-9 of 9
Ying Xie
Close
Sort by
Journal Articles

Cladribine Combined with Homoharringtonine and Cytarabine Achieves a High Remission Rate in Adult Patients with De Novo Acute Myeloid Leukemia, Especially for Adverse-Risk Group: A Prospective, Single Center, Single-Arm, Phase 2 Study

Yuanyuan Zhu, Weijia Huang, Jinya Lin, Zhen Cai, Xiujin Ye, Shanshan Pei, Ying Xie, Xiaoqing Zou, Shaoqi Zhang, He Huang, Jie Sun
Journal: Blood
Blood (2023) 142 (Supplement 1): 1524.
https://doi.org/10.1182/blood-2023-186579
Published: 2023
Journal Articles

Update Results of a Phase II Trial of Venetoclax in Combination with Azacitidine and Chidamide in Relapsed/Refractory Acute Myeloid Leukemia

Jie Zha, Ying Wang, Zhenling Li, Zhijuan Lin, Yun Cai, Tiejun Gong, Wei Yang, Siting Xie, Zhenqi Huang, Pengcheng SHI, Lin Fu, Jinghua Wang, Xiangjun Fu, Xianqi Feng, Liping Su, Jianmin Luo, Lin Yang, Biyun Chen, Ying Xie, Yu Zhu, Xin Du, Yirong Jiang, Zhifeng Li, Bing Xu
Journal: Blood
Blood (2023) 142 (Supplement 1): 4274.
https://doi.org/10.1182/blood-2023-182832
Published: 2023
Journal Articles

Development and Validation of a Machine-Learning Model to Predict POD24 Risk of Follicular Lymphoma

Jie Zha, Qinwei Chen, Wei Zhang, Hongmei Jing, Jingjing Ye, Haifeng Yu, Shuhua Yi, Caixia Li, Zhong Zheng, Wei Xu, Zhifeng Li, Lingyan Ping, Xiaohua He, Liling Zhang, Ying Xie, Feili Chen, Xiuhua Sun, Liping Su, Huilai Zhang, Zhijuan Lin, Haiyan Yang, Weili Zhao, Lugui Qiu, Zhiming Li, Yuqin Song, Bing Xu
Journal: Blood
Blood (2023) 142 (Supplement 1): 3048.
https://doi.org/10.1182/blood-2023-182812
Published: 2023
Journal Articles

Preclinical Studies and Phase II Trial of Venetoclax in Combination with Chidamide and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia

Jie Zha, Hui Zhou, Mengya Zhong, Ying Wang, Xin Du, Tiejun Gong, Zhijuan Lin, Yun Cai, Siting Xie, Chendi Xie, XianQi Feng, ZhenQi Huang, Liping Su, Jianmin Luo, Lin Yang, Zhenling Li, Bi-yun Chen, Ying Xie, Yu Zhu, Pengcheng Shi, Zhifeng Li, Yirong Jiang, Bing Xu
Journal: Blood
Blood (2022) 140 (Supplement 1): 3292–3293.
https://doi.org/10.1182/blood-2022-165261
Published: 2022
Journal Articles

Clinical Characteristics and Outcomes of Follicular Lymphoma Patients with Extranodal Involvement: Analysis of a Series of 1090 Cases in China

Zhijuan Lin, Jie Zha, Shuhua Yi, Zhifeng Li, Lingyan Ping, Xiaohua He, Liyuan Fan, Haifeng Yu, Zhong Zheng, Wei Xu, Feili Chen, Ying Xie, Bi-yun Chen, Huilai Zhang, Li Wang, Kaiyang Ding, Wenyu Li, Haiyan Yang, Weili Zhao, Lugui Qiu, Zhiming LI, Yuqin Song, Bing Xu
Journal: Blood
Blood (2022) 140 (Supplement 1): 11979–11980.
https://doi.org/10.1182/blood-2022-162488
Published: 2022
Journal Articles

PD-1 Inhibitors Can be the First-Line Therapy for Myelodysplastic Syndrome (MDS) --Study on the Bone Marrow Immune Microenvironment of MDS By Multispectral Imaging of Multiplex Immunofluorescence

Minghua Hong, Ying Xie, Jing Zhao, Ting Lu, Jie Sun, He Huang
Journal: Blood
Blood (2022) 140 (Supplement 1): 12303–12304.
https://doi.org/10.1182/blood-2022-166782
Published: 2022
Journal Articles

Developmental Stage and Sex-Specific Role of IGF/IGF1R Signaling in Hematopoietic Stem and Progenitor Cells

Ying Xie, PhD, Xin Hu, PhD, Zhe Li, PhD
Journal: Blood
Blood (2015) 126 (23): 1157.
https://doi.org/10.1182/blood.V126.23.1157.1157
Published: 2015
Journal Articles

Investigation of Polyomavirus BK in the Late-Onset Hemorrhagic Cystitis Following Hematopoietic Stem Cell Transplantation

Yue Han, Ying Xie, Aining Sun, Jian nong Cen, Zi ling Zhu, Haili Gao, Wu Depei
Journal: Blood
Blood (2008) 112 (11): 4345.
https://doi.org/10.1182/blood.V112.11.4345.4345
Published: 2008
Journal Articles

Influence of Protein Kinase C and Calcium in the Course of Thrombin Receptors Activation.

Ying Xie, MD, PhD, Yue Han, MD PhD, De Pei Wu, MD PhD, Aining Sun, MD PhD, Wei Zhang, MD PhD
Journal: Blood
Blood (2007) 110 (11): 3194.
https://doi.org/10.1182/blood.V110.11.3194.3194
Published: 2007